your badges 52W Range $0–$5 9% of range Analyst Rating BUY 7 analysts Price Target $56 +8302% upside P/E · ROE · Net Profit Margin ·

SBFM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $0.67
Market Cap (MRQ) $3M
52W Range $0–$5

SBFM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 6
Ex-date Split Type
June 1, 2026 1-for-10 Reverse
Aug. 8, 2024 1-for-20 Reverse
April 17, 2024 1-for-100 Reverse
Feb. 9, 2022 1-for-200 Reverse
April 6, 2020 1-for-20 Reverse
Feb. 1, 2019 1-for-20 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend SBFM 5Y avg Peer Median Verdict
P/B (MRQ) 0.2 · 0.7 Undervalued
Price / Tangible Book (MRQ) 0.2 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -297.7%
Next Report Nov 11, 2026
PeriodReportEPS ActualEPS EstSurprise
March 31, 2026 May 13, 2026 $-0.25 — —
Dec. 31, 2025 $-5.40 $-2.75 -96.1%
Sept. 30, 2025 $-1.90 $-1.33 -43.3%
June 30, 2025 $-3.90 $-1.12 -247.6%
Dec. 31, 2024 $-1.00 $0.11 -991.3%
Sept. 30, 2024 $-0.94 $9.18 -110.2%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
No annual filings for SBFM

We don't have SEC filings for this ticker yet.

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
No data for this statement

Not enough fundamentals data to build this statement yet.

Institutional owners (13F)

17
Institutional activity — Q1 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
3 (-1 vs prior Q) 4 (0 vs prior Q) 1 (-1 vs prior Q) 5 (+3 vs prior Q) +7K

Compared to Q4 2025. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Company insiders 5 insiders · 3 officers · 3 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Steve N. Slilaty Chief Executive Officer March 4, 2024 P 130,000 0 0 $0
Camille Sebaaly CFO/Secretary Nov. 30, 2022 P 174,465 0 0 $0
Abderrazzak Merzouki Chief Operating Officer Jan. 6, 2021 A 23,342,500 0 0 $0
David Natan Director Aug. 7, 2026 A 68,300 0 0 $0
Advanomics Corp 10% owner Oct. 10, 2016 J 215,014,224 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

SBFM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 7 analysts BUY
Median target $56.00 +8302.1%
2 28.6% Strong Buy
4 57.1% Buy
1 14.3% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

1 analysts · 2026-10-03

Mean target $56.00 +8302.1%

Low$56.00 Mean$56.00 High$56.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
SBFM · · · · · ·
ONCO $2M -0.1 -67.7% -1721.0% -129.5% 77.6%
ADTX $343.6K -0.0 -97.6% -1349028.2% -1183.4% 8.4%
APVO $9M -0.1 · · -217.2% ·
REVB · · · · · ·
BRTX $10M -0.7 -10.3% -3959.4% -547.6% 93.4%
TCRT · -1.5 -50.0% · · ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed May 13, 2026